Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
26%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
15%
ALSO IN OZEM
OZEM
21
HOLDINGS
19%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 19.1% | 13.6% | 13.6% | |
| AMGEN INC | 4.7% | 4.5% | 4.5% | |
| ASTRAZENECA PLC | 4.5% | 4.0% | 4.0% | |
| PFIZER INC | 3.5% | 8.0% | 3.5% | |
MEDX Overweight Relative to OZEM
| ABBVIE INC | 10.3% | |
| NOVARTIS AG-ADR | 6.7% | |
| JOHNSON & JOHNSON | 6.1% | |
| ELI LILLY & CO | 5.5% | |
| MERCK & CO. INC. | 4.7% | |
| ALKERMES PLC | 4.5% | |
| BRISTOL-MYERS SQUIBB CO | 4.3% | |
| BIOGEN IDEC INC | 3.4% | |
| ALNYLAM PHARMACEUTICALS INC | 2.8% | |
| IONIS PHARMACEUTICALS, INC. | 2.7% |
MEDX Underweight Relative to OZEM
| NOVO-NORDISK A/S-SPONS ADR | -11.9% | |
| CHINA PHARMACEUTICAL GROUP | -6.2% | |
| ASCLETIS PHARMA, INC. | -5.5% | |
| KAILERA THERAPEUTICS INC | -5.5% | |
| VIKING THERAPEUTICS, INC. | -5.0% | |
| CHUGAI PHARMACEUTICAL CO LTD | -4.6% | |
| PFIZER INC | -4.5% | |
| HANMI PHARM CO LTD | -4.3% | |
| ZEALAND PHARMA A/S | -3.7% | |
| JIANGSU HENGRUI PHARMACEUT-H | -2.9% |